Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Sigma Pharma International (Pvt.) Ltd.

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx101product presentations
G36generic molecules
DF9dosage-form groups
TA3therapeutic areas
PKR101current price records
REG81registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Portfolio intelligence

Therapeutic mix

Unclassified89 products · 88%
Third-generation cephalosporins6 products · 6%
Proton pump inhibitors4 products · 4%
Fluoroquinolone antibacterials2 products · 2%
Formulation footprint

Dosage forms

Tablet62 products
Injection10 products
Suspension9 products
Capsule8 products
Cream4 products
Sachet3 products
Infusion2 products
Ointment2 products
Gel1 products
Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 StipenQuetiapine 9presentations 100 mg, 200 mg, 25 mg, 300 mg · Tablet #2 CeshCeftriaxone 6presentations 1 g, 250 mg, 500 mg · Injection #3 LetresLevetiracetam 6presentations 250 mg, 500 mg, 750 mg · Tablet #4 LoudClarithromycin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #5 SigvalDivalproex sodium 5presentations 250 mg, 500 mg · Tablet #6 FleelaxRisperidone 4presentations 1 mg, 2 mg, 3 mg, 4 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1414% of comparable products
Near market median57within ±5% of median
Above market median2627% of comparable products
Lowest-price equivalents0ties included
Company median price position +1.6% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Oralite 2.6 gSodium chloride · Sachet · 20's PKR 19.42/sachet-21.8% vs market median Stipen 200 mgQuetiapine · Tablet · 30's PKR 75.35/tablet-14.8% vs market median Antif /g 10 mgClotrimazole · Cream · 15gm PKR 5.95/g-12.7% vs market median Amdova 10 mgAmlodipine · Tablet · 20's PKR 15.46/tablet-11.1% vs market median Sigval 500 mgDivalproex sodium · Tablet · 30's PKR 10.68/tablet-10.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,362 products · 118 generics 29shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 25shared generics Valor Pharmaceuticals218 products · 97 generics 25shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 25shared generics Genome Pharmaceuticals (Pvt.) Ltd,149 products · 71 generics 25shared generics CCL Pharmaceuticals (Pvt.) Ltd.243 products · 90 generics 24shared generics
Regulatory & price activity

Observed database signals

Registration numbers81
Price-history records119
Products with price history14
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date27 Jul 2026
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

101 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Voclir w/w Aciclovir 5 % Cream 10gm 108592 PKR 362.58 PKR 36.26/g 5% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.